ArticleMovement disorders : official journal of the Movement Disorder Society2019

Cancer outcomes among Parkinson's disease patients with leucine rich repeat kinase 2 mutations, idiopathic Parkinson's disease patients, and nonaffected controls.

Ilir Agalliu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.